Regencell Bioscience Holdings Limited, a herbal medicine biotech firm, has experienced an astonishing 46,000% surge in its stock value in 2025, despite generating no revenue since its inception. This Hong Kong-based company, specializing in traditional Chinese medicine for neurological conditions, saw its market capitalization soar to $30 billion.
Related Posts
MCG Weather: Rain to interrupt 4th Test on Day 4?
Day 4 of the India vs Australia Test at the MCG promises better weather conditions with minimal rain interruptions. Morning and afternoon sessions expect mild […]
Social media sparks meme fest after Pandya’s send-off to Babar Azam
Hardik Pandya dismissed Babar Azam during the ICC Champions Trophy 2025 with a fiery delivery. He added a bold “bye-bye” wave, sparking a lot of […]
